Feature Article | Beyond the check: Leen Kawas on building comprehensive support ecosystems for biotech entrepreneurs
- chance51029
- Jan 2
- 1 min read

Most VC in biotech still runs like a transaction: fund the science, take a board seat, check in quarterly. Leen Kawas argues that model is built for software, not drug development. This article breaks down her “ecosystem” approach to investing, why scientists often struggle with the networking side of building a company, and how founders can use advisory boards, conferences, and even non-investing VCs as strategic infrastructure. The takeaway is practical: in biotech, the right network can matter as much as the check.



Comments